Cannabis Bioscience International Holdings, Inc. (CBIH)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -479.38 Thousand | -913.16 Thousand | -855.7 Thousand | -507.7 Thousand | -223.04 Thousand | -6836.00 |
| Net Income | -651.34 Thousand | -1.03 Million | -885.17 Thousand | -159.3 Thousand | -226.46 Thousand | -1.28 Million |
| Depreciation & Amortization | -11.75 Thousand | 36.37 Thousand | - | 3644.00 | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 12 Thousand | - | - | - | - |
| Change in working capital | 48.36 Thousand | 164.32 Thousand | 15.55 Thousand | -352.04 Thousand | 3158.00 | 1.02 Million |
| Other non-cash items | 135.34 Thousand | -83.06 Thousand | -33.63 Thousand | 90.86 Thousand | -2893.00 | 249.63 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 471.22 Thousand | 890.09 Thousand | 846.36 Thousand | 421.37 Thousand | 317 Thousand | 13.74 Thousand |
| Debt repayment | -401.22 Thousand | -88.12 Thousand | -33.07 Thousand | -161.37 Thousand | -141.1 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -1000.00 | -600.00 | - |
| Common Stock Issuance | 70 Thousand | 801.96 Thousand | 813.29 Thousand | 261 Thousand | 176.5 Thousand | - |
| Other Financing Activities | - | - | - | - | - | 13.74 Thousand |
| Accounts receivables | -10.18 Thousand | -4935.00 | -4319.00 | -6212.00 | 2645.00 | - |
| Accounts payables | 84.78 Thousand | 43.08 Thousand | 51.86 Thousand | -77.36 Thousand | 513.00 | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -28.64 Thousand | 126.17 Thousand | -31.98 Thousand | -268.46 Thousand | - | 1.02 Million |
| Cash at beginning of period | 8913.00 | 31.98 Thousand | 41.32 Thousand | 127.65 Thousand | 31.74 Thousand | 147.57 Thousand |
| Cash at end of period | 755.00 | 8913.00 | 31.98 Thousand | 41.32 Thousand | 127.65 Thousand | 6931.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -8158.00 | -23.06 Thousand | -9341.00 | -86.33 Thousand | 95.91 Thousand | -140.63 Thousand |
| Free Cash Flow | -479.38 Thousand | -913.16 Thousand | -855.7 Thousand | -507.7 Thousand | -223.04 Thousand | -6836.00 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -76.3 Thousand | -651.34 Thousand | -135.93 Thousand | -209.19 Thousand | -124.42 Thousand | -125.26 Thousand |
| Depreciation & Amortization | 8133.00 | -11.75 Thousand | 39.87 Thousand | 6562.00 | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -62.24 Thousand | 48.36 Thousand | -67.61 Thousand | 117.81 Thousand | 43.22 Thousand | 21.16 Thousand |
| Other non-cash items | 100 Thousand | 135.34 Thousand | -10.76 Thousand | 31.36 Thousand | -160.36 Thousand | -45.37 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 3.00 | - | -2.92 | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 30.62 Thousand | 471.22 Thousand | 174.4 Thousand | 13.69 Thousand | 194.11 Thousand | 95.49 Thousand |
| Debt repayment | -30.62 Thousand | -401.22 Thousand | -179.4 Thousand | -78.13 Thousand | -129.43 Thousand | -20.49 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | 18.9 Thousand | -18.9 Thousand | - |
| Common Stock Issuance | - | 70 Thousand | -5000.00 | 631.16 | -382.56 | 74.99 Thousand |
| Other Financing Activities | - | - | - | -83.96 Thousand | 83.96 Thousand | - |
| Accounts receivables | 2963.00 | -10.18 Thousand | -3064.28 | 1694.33 | 8631.16 | -17.43 Thousand |
| Accounts payables | -59.78 Thousand | 84.78 Thousand | -61.43 Thousand | 45.01 Thousand | 34.45 Thousand | 67.24 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -5418.00 | -28.64 Thousand | -48.89 Thousand | 71.1 Thousand | 146.09 | -28.64 Thousand |
| Cash at beginning of period | 755.00 | 8913.00 | 794.00 | 337.00 | 4750.00 | 8913.00 |
| Cash at end of period | 969.00 | 755.00 | 755.00 | 794.00 | 337.00 | 4750.00 |
| Capital Expenditure | 3.00 | - | -2.92 | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 214.00 | -8158.00 | -39.00 | 457.00 | -4413.00 | -4163.00 |
| Free Cash Flow | -30.41 Thousand | -479.38 Thousand | -174.44 Thousand | -13.31 Thousand | -198.48 Thousand | -99.66 Thousand |
0QDX
0J7X
004870
ALFRE
KENH
0839